Showing results (121-130 of 861) with videos related to

Sort By:
Pageof 87
Lupus Science & Medicine|May 21, 2021
Suppressor of cytokine signalling 3 (SOCS3) expressed in podocytes attenuates glomerulonephritis and suppresses autoantibody production in an imiquimod-induced lupus modelMasashi Fukuta, Kotaro Suzuki, Shotaro Kojima, et al.
Lupus Science & Medicine|July 1, 2025
Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohortIñigo Rua-Figueroa, Natalia Pérez-Veiga, Esther Rodríguez-Almaraz, et al.
Lupus Science & Medicine|July 14, 2025
Systemic Lupus International Collaborating Clinics-Frailty Index predicts hospitalisations in the Almenara Lupus CohortAnubhav Singh, Rocio Violeta Gamboa-Cárdenas, Victor Román Pimentel-Quiroz, et al.
Lupus Science & Medicine|December 4, 2025
New efforts to incorporate patient-reported outcomes into lupus clinical trials: report of the community meeting convened by the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), 16-17 October 2024Patricia Katz, Anca D Askanase, Nandan Baruah, et al.
Lupus Science & Medicine|December 20, 2024
Lupus nephritis randomised controlled trials: evidence gaps and under-represented groupsAlberto Nordmann-Gomes, Gabriel Cojuc-Konigsberg, Adriana Hernández-Andrade, et al.
Lupus Science & Medicine|February 12, 2025
Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocolMaría Galindo-Izquierdo, Noemí Bahamontes-Rosa, Berta Sarto-Ferres, et al.
Lupus Science & Medicine|February 18, 2025
Autoimmune encephalitis associated with anti-LGI1 antibody: a potential cause of neuropsychiatric systemic lupus erythematosusSixian Chen, Haitao Ren, Siyuan Fan, et al.
Lupus Science & Medicine|January 21, 2025
Ultrasonographic assessment of optic nerve: does it help in lupus-induced optic neuropathy?Amira Elsonbaty, Doaa M Mahmoud, Sara Alattar, et al.
Lupus Science & Medicine|January 10, 2025
Postmarketing safety evaluation of belimumab: a pharmacovigilance analysisHuqun Li, Wenlong Xie, Chongshu Wang, et al.
Lupus Science & Medicine|January 6, 2025
Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trialsAmit Saxena, Cristina Sorrento, Peter Izmirly, et al.
Pageof 87